A 28-year-old woman from rural Rajasthan presents with a 6-month history of progressive eye irritation, photophobia, and purulent discharge from both eyes. On examination, she has conjunctival injection, upper tarsal papillae, and fine linear scars on the upper tarsal conjunctiva. Giemsa staining of conjunctival scrapings reveals intracytoplasmic inclusions in epithelial cells. Her 4-year-old daughter has similar symptoms. What is the most likely diagnosis?

Explanation

## Clinical Diagnosis: Trachoma (TF Stage) ### Key Clinical Features **Key Point:** The constellation of chronic conjunctivitis with tarsal papillae, linear scars (Arlt's line), intracytoplasmic inclusions on Giemsa staining, and family clustering in a rural endemic area is pathognomonic for active trachoma. ### Pathognomonic Findings **High-Yield:** Trachoma is caused by *Chlamydia trachomatis* serovars A, B, Ba, and C. The disease progresses through WHO-defined stages: | Stage | Clinical Features | Pathology | |-------|-------------------|----------| | **TF (Trachomatous Inflammation-Follicular)** | Upper tarsal follicles, papillae, conjunctival injection | Active chlamydial infection, intracytoplasmic inclusions | | **TI (Trachomatous Inflammation-Intense)** | Severe papillary hypertrophy, thick mucoid discharge | Intense inflammatory response | | **TS (Trachomatous Scarring)** | Linear scars (Arlt's line), trichiasis | Fibrosis and cicatrization | | **TT (Trachomatous Trichiasis)** | Inturned eyelashes, corneal abrasion | Mechanical trauma | | **CO (Corneal Opacity)** | Pannus formation, corneal scarring, blindness | Irreversible vision loss | ### Diagnostic Confirmation **Clinical Pearl:** Giemsa staining showing intracytoplasmic inclusions (Halberstaedter-Prowazek bodies) in epithelial cells is the gold standard for confirming active trachoma in resource-limited settings. Modern methods include PCR and direct immunofluorescence, but Giemsa remains the field standard in endemic areas. ### Epidemiology **Key Point:** Trachoma is the leading infectious cause of blindness worldwide. It is endemic in rural, poor-sanitation areas of Africa, Asia, and Latin America. Transmission occurs via direct contact, fomites, and flies. Family clustering (as seen with the daughter) is typical. ### Treatment **Mnemonic: A-B-C-D-E** (WHO SAFE strategy) - **S**urgery for trichiasis - **A**ntibiotics (azithromycin 20 mg/kg single dose for active TF/TI) - **F**acial cleanliness education - **E**nvironmental improvement (water, sanitation) **Clinical Pearl:** A single dose of azithromycin (20 mg/kg) is now preferred over 6 weeks of tetracycline ointment for active trachoma, improving compliance and efficacy. ### Why This Case Is Trachoma 1. **Chronic presentation** (6 months) with progressive symptoms 2. **Rural endemic setting** (Rajasthan) 3. **Bilateral involvement** with family clustering 4. **Tarsal papillae and linear scars** (Arlt's line) — classic stigmata 5. **Giemsa-positive intracytoplasmic inclusions** — diagnostic confirmation 6. **Age group** (28 years) — consistent with active TF in endemic areas [cite:Park 26e Ch 7]